Ignite Creation Date:
2024-05-06 @ 8:09 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06276868
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-26
First Post:
2023-11-14
Brief Title:
Darsilide Combined With AI Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HRHER2 Breast Cancer
Sponsor:
Henan Cancer Hospital
Organization:
Henan Cancer Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-14
First Submit QC Date:
February 23 2024
Study First Post Date:
2024-02-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-23
Last Update Post Date:
2024-02-26
Last Update Post Date Type:
ACTUAL